Lineage Cell Therapeutics Inc (LCTX) — Financial Flexibility Index
Lineage Cell Therapeutics Inc (LCTX) has a Financial Flexibility Index of -0.05x as of September 2025. Free cash flow of $-3.60 Million (operating CF $-3.62 Million minus capex $12.00K) represents 0% of total liabilities ($68.84 Million). Also explore net asset momentum of Lineage Cell Therapeutics Inc to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Lineage Cell Therapeutics Inc Financial Flexibility Index (1991–2024)
Historical Financial Flexibility Index trend for Lineage Cell Therapeutics Inc across 34 annual periods. Check LCTX capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Lineage Cell Therapeutics Inc (1991–2024)
Year-by-year free cash flow to debt coverage for Lineage Cell Therapeutics Inc. For the full company profile including market capitalisation, see market value of Lineage Cell Therapeutics Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.62x | $-22.53 Million | $-23.09 Million | $36.21 Million | ▲ +13.0% |
| 2023 | -0.72x | $-27.89 Million | $-28.57 Million | $39.00 Million | ▼ -2613.5% |
| 2022 | 0.03x | $1.47 Million | $1.06 Million | $51.73 Million | ▲ +110.3% |
| 2021 | -0.28x | $-23.21 Million | $-23.56 Million | $83.65 Million | ▲ +81.9% |
| 2020 | -1.54x | $-19.69 Million | $-19.75 Million | $12.82 Million | ▲ +30.6% |
| 2019 | -2.21x | $-31.51 Million | $-31.95 Million | $14.23 Million | ▲ +24.5% |
| 2018 | -2.93x | $-27.59 Million | $-30.88 Million | $9.41 Million | ▲ +9.8% |
| 2017 | -3.25x | $-29.19 Million | $-30.52 Million | $8.98 Million | ▲ +1.4% |
| 2016 | -3.30x | $-39.80 Million | $-42.33 Million | $12.06 Million | ▼ -53.2% |
| 2015 | -2.15x | $-39.21 Million | $-44.54 Million | $18.21 Million | ▲ +31.7% |
| 2014 | -3.15x | $-38.37 Million | $-38.85 Million | $12.18 Million | ▼ -79.0% |
| 2013 | -1.76x | $-27.23 Million | $-29.51 Million | $15.47 Million | ▲ +50.2% |
| 2012 | -3.53x | $-19.28 Million | $-19.68 Million | $5.45 Million | ▼ -22.3% |
| 2011 | -2.89x | $-12.63 Million | $-13.59 Million | $4.37 Million | ▼ -52.3% |
| 2010 | -1.90x | $-7.30 Million | $-7.73 Million | $3.85 Million | ▼ -7.8% |
| 2009 | -1.76x | $-4.20 Million | $-4.26 Million | $2.39 Million | ▼ -1172.3% |
| 2008 | -0.14x | $-744.37K | $-1.60 Million | $5.38 Million | ▲ +63.9% |
| 2007 | -0.38x | $-1.23 Million | $-1.24 Million | $3.22 Million | ▲ +23.0% |
| 2006 | -0.50x | $-1.25 Million | $-1.26 Million | $2.52 Million | ▲ +24.2% |
| 2005 | -0.66x | $-1.41 Million | $-1.41 Million | $2.16 Million | ▲ +49.8% |
| 2004 | -1.31x | $-1.54 Million | $-1.54 Million | $1.18 Million | ▼ -599.1% |
| 2003 | -0.19x | $-654.14K | $-654.14K | $3.50 Million | ▲ +76.6% |
| 2002 | -0.80x | $-2.13 Million | $-2.13 Million | $2.67 Million | ▲ +49.3% |
| 2001 | -1.57x | $-3.20 Million | $-3.21 Million | $2.04 Million | ▲ +88.3% |
| 2000 | -13.41x | $-4.82 Million | $-4.86 Million | $359.75K | ▼ -88.6% |
| 1999 | -7.11x | $-4.23 Million | $-4.39 Million | $595.51K | ▼ -42.2% |
| 1998 | -5.00x | $-2.00 Million | $-2.10 Million | $400.00K | ▼ -650.0% |
| 1997 | -0.67x | $-1.20 Million | $-1.30 Million | $1.80 Million | ▲ +93.7% |
| 1996 | -10.50x | $-2.10 Million | $-2.10 Million | $200.00K | ▲ +0.0% |
| 1995 | -10.50x | $-2.10 Million | $-2.10 Million | $200.00K | ▼ -121.1% |
| 1994 | -4.75x | $-1.90 Million | $-2.00 Million | $400.00K | ▲ +70.3% |
| 1993 | -16.00x | $-1.60 Million | $-1.60 Million | $100.00K | ▼ -23.1% |
| 1992 | -13.00x | $-1.30 Million | $-1.30 Million | $100.00K | ▼ -333.3% |
| 1991 | -3.00x | $-600.00K | $-600.00K | $200.00K | — |